Jyotsna Pilli

Jyotsna Pilli

Auto-generated profile, based on publicly available information

Jyotsna Pilli

Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2019 in Circulation
Verified
Journal Article
Open access
PDF file
QYQiujun Yu
Qiujun Yu
YTYi-Yin Tai
Yi-Yin Tai
YTYing Tang
Ying Tang
JZJingsi Zhao
Jingsi Zhao
VNVinny Negi
Vinny Negi
SCStephen Chan
Stephen Chan
Background: Deficiencies of iron-sulfur (Fe-S) clusters, metal complexes that control redox state and mitochondrial metabolism, have been linked to pulmonary hypertension (PH), a deadly vascular disease with poorly defined molecular origins. BOLA3 (BolA Family Member 3) regulates Fe-S biogenesis, and mutations in BOLA3 result in multiple mitochondrial dysfunction syndrome, a fatal disorder associated with PH. The mechanistic role of BOLA3 in PH remains undefined. Methods: In vitro assessment of BOLA3 regulation and gain- and loss-of-function assays were performed in human pulmonary artery endothelial cells using siRNA and lentiviral vectors expressing the mitochondrial isoform of BOLA3. Polymeric nanoparticle 7C1 was used for lung endothelium-specific delivery of BOLA3 siRNA oligonucleotides in mice. Overexpression of pulmonary vascular BOLA3 was performed by orotracheal transgene delivery of adeno-associated virus in mouse models of PH. Results: In cultured hypoxic pulmonary artery endothelial cells, lung from human patients with Group 1 and 3 PH, and multiple rodent models of PH, endothelial BOLA3 expression was downregulated, which involved hypoxia inducible factor-2α–dependent transcriptional repression via histone deacetylase 1–mediated histone deacetylation. In vitro gain- and loss-of-function studies demonstrated that BOLA3 regulated Fe-S integrity, thus modulating lipoate-containing 2-oxoacid dehydrogenases with consequent control over glycolysis and mitochondrial respiration. In contexts of siRNA knockdown and naturally occurring human genetic mutation, cellular BOLA3 deficiency downregulated the glycine cleavage system protein H, thus bolstering intracellular glycine content. In the setting of these alterations of oxidative metabolism and glycine levels, BOLA3 deficiency increased endothelial proliferation, survival, and vasoconstriction while decreasing angiogenic potential. In vivo, pharmacological knockdown of endothelial BOLA3 and targeted overexpression of BOLA3 in mice demonstrated that BOLA3 deficiency promotes histological and hemodynamic manifestations of PH. Notably, the therapeutic effects of BOLA3 expression were reversed by exogenous glycine supplementation. Conclusions: BOLA3 acts as a crucial lynchpin connecting Fe-S–dependent oxidative respiration and glycine homeostasis with endothelial metabolic reprogramming critical to PH pathogenesis. These results provide a molecular explanation for the clinical associations linking PH with hyperglycinemic syndromes and mitochondrial disorders. These findings also identify novel metabolic targets, including those involved in epigenetics, Fe-S biogenesis, and glycine biology, for diagnostic and therapeutic development.

3 April 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
SCStephen D. Carter
Stephen D. Carter
CHCheri M. Hampton
Cheri M. Hampton
RLRobert Langlois
Robert Langlois
RMRoberto Melero
Roberto Melero
ZFZachary J. Farino
Zachary J. Farino
ZFZachary Z. Freyberg
Zachary Z. Freyberg
Ribosome-associated vesicles are a novel, dynamic ER-derived organelle.

1 January 2006 in Aquatic Toxicology
Verified
Journal Article
Closed access
THThomas Hassenklöver
Thomas Hassenklöver
SPSabine Predehl
Sabine Predehl
JPJyotsna Pilli
Jyotsna Pilli
JLJessica Ledwolorz
Jessica Ledwolorz
MAMichael Assmann
Michael Assmann
UBUlf Bickmeyer
Ulf Bickmeyer

1 January 2018 in Neuropharmacology
Verified
Journal Article
Closed access
MBMegan L. Brady
Megan L. Brady
JPJyotsna Pilli
Jyotsna Pilli
JLJoshua M. Lorenz-Guertin
Joshua M. Lorenz-Guertin
SDSabyasachi Das
Sabyasachi Das
CMCharles E. Moon
Charles E. Moon
TJTija C. Jacob
Tija C. Jacob

1 April 2019 in Redox Biology
Verified
Journal Article
Open access
BCBalu K. Chacko
Balu K. Chacko
Matthew Ryan SmithMatthew Ryan Smith
Matthew Ryan Smith
MJMichelle S. Johnson
Michelle S. Johnson
GBGloria Benavides
Gloria Benavides
MCMatilda L. Culp
Matilda L. Culp
VDVictor Darley-Usmar
Victor Darley-Usmar
Mitochondria possess reserve bioenergetic capacity, supporting protection and resilience in the face of disease. Approaches are limited to understand factors that impact mitochondrial functional reserve in humans. We applied the mitochondrial stress test (MST) to platelets from healthy subjects and found correlations between energetic parameters and mitochondrial function. These parameters were not correlated with mitochondrial complex I-IV activities, however, suggesting that other factors affect mitochondrial bioenergetics and metabolism. Platelets from African American patients with sickle cell disease also differed from controls, further showing that other factors impact mitochondrial bioenergetics and metabolism. To test for correlations of platelet metabolites with energetic parameters, we performed an integrated analysis of metabolomics and MST parameters. Subsets of metabolites, including fatty acids and xenobiotics correlated with mitochondrial parameters. The results establish platelets as a platform to integrate bioenergetics and metabolism for analysis of mitochondrial function in precision medicine.